drugIndia
Cart
Glinvika Tablet ER

Glinvika Tablet ER

Gliclazide (80mg) + Metformin (500mg)

Agresco Pharma
144.80181.0020% OFF
In Stock
1
Safe & Secure
Easy Returns
24/7 Support
Delivery
drugIndia verified
Save 64%
Best Alternative100% Match

Opimet-G Tablet SR

Overseas Pharma Pvt Ltd

Gliclazide 80mg
Opimet-G Tablet SR

Pack Size

1 units

Price

52.5020% off
Opimet-G Tablet SR is 100% same as Glinvika Tablet ER
Better ValueSame QualitySame Effectiveness

Save ₹92

that's 64% off!

composition
  1. Gliclazide 80mg
  2. Metformin 500mg
Buy Now
144.8020% OFF
181.00

About This Medicine

Product description & overview

Glinvika Tablet ER: A Powerful Combination for Blood Sugar Control

Glinvika Tablet ER (80mg Gliclazide + 500mg Metformin) is a once-daily, extended-release tablet designed to effectively manage blood sugar levels in adults with Type 2 Diabetes. This carefully formulated blend combines the action of two powerful antidiabetic medications:

* Gliclazide: A sulfonylurea that stimulates insulin release from the pancreas, reducing glucose production in the liver and increasing glucose utilization by muscle cells.
* Metformin: A first-line oral hypoglycemic drug that improves cellular uptake of glucose and reduces hepatic glucose production.

Features:

* Extended-Release Formulation: Provides sustained blood sugar control throughout the day with a single dose.
* Convenience & Accuracy: Offers precise dosage administration for optimal management of Type 2 Diabetes.
* Proven Efficacy: Gliclazide + Metformin demonstrates effectiveness in lowering fasting and postprandial glucose levels, improving glycemic control, and reducing complications associated with diabetes.

Consult your healthcare professional before starting any new medication. Glinvika Tablet ER is a prescription-only product and should be used under the guidance of a qualified medical practitioner for optimal therapeutic effect.

Active composition

Gliclazide 80 mg

+1 more active ingredient

About Gliclazide

Gliclazide is an oral hypoglycemic agent used to treat type 2 diabetes mellitus. It works by stimulating insulin release from the pancreas, thereby lowering blood sugar levels. Gliclazide is effective in managing diabetes and preventing complications associated with high blood sugar. Common side effects may include nausea and stomach discomfort, but these usually resolve over time. In summary, Gliclazide is important for controlling blood sugar levels in diabetic patients.

How It Works

Gliclazide stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues.

Medicine Strength
80 mg

All Active Ingredients

Gliclazide80 mg
Metformin500 mg

Metformin

Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.

Dosage & How to Use

Dosage information not available. Please consult your doctor or pharmacist.

Safety Advice

Important precautions

Side Effect Occurrence

Based on clinical trials and patient reports.

Overall Tolerance

Most patients tolerate well

Only 2.3% reported effects

Common Side Effects

Headache8%
Nausea5%
Dizziness3%
Fatigue2%
Rash1%
Higher
Lower

Safety Advice

Alcohol

It is unsafe to consume alcohol with Glinvika Tablet ER.

High Risk

Pregnancy

Glinvika Tablet ER is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.

Medical Advice

Driving

Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.

Exercise Caution

Liver

Glinvika Tablet ER should be used with caution in patients with liver disease. Dose adjustment of Glinvika Tablet ER may be needed. Please consult your doctor. Glinvika Tablet ER is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.

Regular Checkup

Breastfeeding

Glinvika Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Consult Doctor

Kidney

Glinvika Tablet ER should be used with caution in patients with kidney disease. Dose adjustment of Glinvika Tablet ER may be needed. Please consult your doctor. Use of Glinvika Tablet ER is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.

Regular Checkup

Customer Reviews

0 reviews for Glinvika Tablet ER